Data Science, Cheminformatics & AI: Lab-in-the-Loop Hit Finding
Novartis
Quick summary
Market check
How this pay compares to similar roles
This role pays less than 84% of similar roles. Most pay $177,137–$241,789 — the shaded band above. At the midpoint, this role pays about $159k versus about $209k for comparable roles.
Based on 240 similar postings.
Employer
AbbVie is a global biopharmaceutical company focused on discovering and delivering innovative medicines and solutions in immunology, oncology, neuroscience, and eye care. Its products include Humira, Skyrizi, and Rinvoq.
AbbVie currently has 141 open roles on FindRole.
Listed pay typically runs $109,500–$208,500 across 131 roles with salary data.
Most-posted roles
At a glance
Senior Scientist I - II, Computational HitGen / LeadGen joins the HGLG team to drive AI-enabled drug discovery across a small molecule portfolio. This role involves identifying, developing, and deploying innovative methods for computational hit generation while collaborating with medicinal chemists and structural biologists. The successful candidate will establish project-relevant criteria, select optimal methodologies, and develop workflows to predict binding affinities, design compounds with specific pharmacological properties, and sample both enumerated and AI-generated chemical spaces. Key responsibilities include evaluating synthetic tractability of designs from generative AI and communicating complex technical rationale to non-specialists. Required expertise includes machine learning, deep learning, cheminformatics, and Python programming. The role focuses on solving challenges in hit and lead generation by utilizing advanced computational tools for molecular design, pose prediction, and retrosynthetic analysis within an early-stage drug discovery context.
Skills
What you'll do
What we're looking for
More like this
Novartis
AbbVie
AbbVie
Gilead Sciences
AbbVie
MSD